Skip to main content
. Author manuscript; available in PMC: 2022 Feb 10.
Published in final edited form as: J Control Release. 2020 Dec 27;330:575–586. doi: 10.1016/j.jconrel.2020.12.045

Schematic 1.

Schematic 1.

(A) Schematic representation of preparing PEG hydrogel by one-step mixing through SH-VS Michael addition. SH: thiol; VS: vinyl sulfone. (B) Schematic view of phage display used to screen peptides that specifically bind to human NT-3 proteins. (C) Schematic representation of affinity-controlled NT-3 release from PEG hydrogels conjugated with peptides that can reversibly bind to NT-3 proteins in the gel.